It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients
Author
Jia, Bei 1 ; Wang, Liru 2 ; Claxton, David F 1 ; Ehmann, W Christopher 1 ; Rybka, Witold B 1 ; Shin Mineishi 1 ; Rizvi, Syed 3 ; Shike, Hiroko 4 ; Bayerl, Michael 4 ; Schell, Todd D 5 ; Hohl, Raymond J 1 ; Zheng, Hong 1
1 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA
2 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA; Fu Xing Hospital, Capital Medical University, Beijing, China
3 Department of Medicine, Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX, USA
4 Department of Pathology, Penn State University College of Medicine, Hershey, PA, USA
5 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA; Depatment of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA
1 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA
2 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA; Fu Xing Hospital, Capital Medical University, Beijing, China
3 Department of Medicine, Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX, USA
4 Department of Pathology, Penn State University College of Medicine, Hershey, PA, USA
5 Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA; Depatment of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA
Pages
1-5
Publication year
2018
Publication date
Mar 2018
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2019482784
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.